LUNG
Income statement / Annual
Last year (2023), Pulmonx Corporation's total revenue was $68.68 M,
an increase of 27.98% from the previous year.
In 2023, Pulmonx Corporation's net income was -$60.84 M.
See Pulmonx Corporation’s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
Operating Revenue |
$68.68 M
|
$53.66 M
|
$48.42 M
|
$32.73 M
|
$32.60 M
|
$20.00 M
|
Cost of Revenue |
$17.92 M |
$13.80 M |
$12.79 M |
$11.53 M |
$10.18 M |
$7.72 M |
Gross Profit |
$50.75 M |
$39.87 M |
$35.63 M |
$21.20 M |
$22.41 M |
$12.29 M |
Gross Profit Ratio |
0.74 |
0.74 |
0.74 |
0.65 |
0.69 |
0.61 |
Research and Development
Expenses |
$18.08 M
|
$15.40 M
|
$13.06 M
|
$7.46 M
|
$6.05 M
|
$6.99 M
|
General & Administrative
Expenses |
$89.81 M
|
$77.01 M
|
$64.77 M
|
$44.57 M
|
$34.20 M
|
$20.35 M
|
Selling & Marketing
Expenses |
$4.80 M
|
$6.10 M
|
$5.10 M
|
$1.50 M
|
$600,000.00
|
$100,000.00
|
Selling, General &
Administrative Expenses |
$94.61 M
|
$83.11 M
|
$69.87 M
|
$46.07 M
|
$34.20 M
|
$20.35 M
|
Other Expenses |
$0.00 |
-$396,000.00 |
-$585,000.00 |
$3.28 M |
-$617,000.00 |
-$916,000.00 |
Operating Expenses |
$112.69 M |
$98.50 M |
$82.93 M |
$53.53 M |
$40.25 M |
$27.34 M |
Cost And Expenses |
$130.61 M |
$112.30 M |
$95.72 M |
$65.07 M |
$50.43 M |
$35.06 M |
Interest Income |
$5.57 M |
$1.53 M |
$400,000.00 |
$213,000.00 |
$432,000.00 |
$21,000.00 |
Interest Expense |
$3.23 M |
$1.07 M |
$829,000.00 |
$3.18 M |
$2.32 M |
$2.52 M |
Depreciation &
Amortization |
$1.95 M
|
$4.00 M
|
$3.16 M
|
$400,000.00
|
$1.20 M
|
$270,000.00
|
EBITDA |
-$55.09 M
|
-$55.99 M
|
-$46.62 M
|
-$28.44 M
|
-$16.82 M
|
-$15.68 M
|
EBITDA Ratio |
-0.8 |
-1.07 |
-0.98 |
-0.88 |
-0.54 |
-0.78 |
Operating Income Ratio
|
-0.9
|
-1.09
|
-0.98
|
-0.99
|
-0.55
|
-0.75
|
Total Other
Income/Expenses Net |
$1.66 M
|
$67,000.00
|
-$1.01 M
|
$314,000.00
|
-$2.50 M
|
-$3.42 M
|
Income Before Tax |
-$60.27 M |
-$58.57 M |
-$48.32 M |
-$32.02 M |
-$20.34 M |
-$18.47 M |
Income Before Tax Ratio
|
-0.88
|
-1.09
|
-1
|
-0.98
|
-0.62
|
-0.92
|
Income Tax Expense |
$571,000.00 |
$353,000.00 |
$343,000.00 |
$213,000.00 |
$363,000.00 |
$12,000.00 |
Net Income |
-$60.84 M |
-$58.92 M |
-$48.66 M |
-$32.23 M |
-$20.70 M |
-$18.48 M |
Net Income Ratio |
-0.89 |
-1.1 |
-1.01 |
-0.98 |
-0.64 |
-0.92 |
EPS |
-1.6 |
-1.59 |
-1.35 |
-0.9 |
-0.58 |
-0.89 |
EPS Diluted |
-1.6 |
-1.59 |
-1.35 |
-0.9 |
-0.58 |
-0.89 |
Weighted Average Shares
Out |
$37.97 M
|
$37.10 M
|
$36.13 M
|
$35.69 M
|
$35.43 M
|
$20.71 M
|
Weighted Average Shares
Out Diluted |
$37.97 M
|
$37.10 M
|
$36.13 M
|
$35.69 M
|
$35.43 M
|
$20.71 M
|
Link |
|
|
|
|
|
|